Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease

Neuroscience

• Alpha-Synuclein 100%
• Treatment of Parkinson's Disease 100%
• Parkinson's Disease 83%
• Lewy Body 50%
• Amino Acid 16%
• Stereotypic Movement Disorder 16%
• Synaptic Transmission 16%
• Synaptic Plasticity 16%
• Tremor 16%
• Acid Protein 16%
• Cell Loss 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Parkinson's Disease 100%
• Alpha Synuclein 100%
• Lewy Body 50%
• Diseases 33%
• Amino Acid 16%
• Motor Dysfunction 16%
• Acid Protein 16%